Interferon alfa-2b (IFN
a-2b)
l
Description
Recombinant Human Interferon alfa-2b is a sterile
protein product for injection. rHuIFN
a-2b
is produced by recombinant DNA technology by Yeast
carrying a genetically engineered plasmid containing
human interferon alfa-2b gene. It is a highly
purified protein containing 165 amino acids, and has
a molecular weight of approximately19.3kD.
l
Indication
1.
Treatment of viral diseases including acute
and chronic hepatitis, herpes zoster, condylomata
acuminate
2.
Treatment of hairy cell leukemia
3.
Treatment of malignant melanoma
4.
Treatment of follicular lymphoma
5.
Treatment of condylomata acuminate
6.
Indicated for AIDS-Related Kaposi’s Sarcoma
l
Pharmaceutical particulars
Sterile, clear, colorless and
preservative-free liquid for injection in vials.
Dosage: 3
million IU (0.3ml)/vial
Reference: Current European
Pharmacopoeia and Internal Requirement
Specific activity: ≥2.0×108 IU/mg
Purity (HPLC, SDS-PAGE): ≥98%
l
Composition
Active
ingredient: Recombinant Human Interferon alfa-2b (rHuIFN
a-2b)
Inactive ingredients: Sodium chloride,
Polysobate-80, Dibasic Sodium Phosphate
and Monobasic Sodium Phosphate.
l
Shelf life and storage conditions
Finished
formulation |
Store
at 2-8℃
for 2 years |
API
(Concentrated solution) |
Store
at -70℃
for 12 months |